Publication | Open Access
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
62
Citations
43
References
2015
Year
OncologyNovel TherapyMedicinePathologyCombination TherapyMicrorna DetectionBioengineered Mir-34a ProdrugCancer TreatmentOsteosarcoma GrowthCancer BiologyRadiation OncologyCancer ResearchTumor MicroenvironmentTumor BiologyCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1